P2RY2 and neoplasm: Over the years extensive work has gone into developing selective antagonists targeting P2Y2 for the purpose of preventing tumor metastasis, skin fibrosis, cystic fibrosis, inflammation, and atherosclerosis (Burnstock 2017).